T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC
Ling Yi(Capital Medical University), Yi Han(Zhejiang Chinese Medical University), Panjian Wei(Capital Medical University), Tianyu Ma(Capital Medical University), Hongtao Zhang(Chinese Academy of Sciences), Zhidong Liu(Capital Medical University), Ziwei Xu(Capital Medical University), Bo Xiao(Central South University), Chong Wang(University of Hong Kong), Nanying Che
Cited by 13
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Residual Convolutional Neural Network for the Determination of <i>IDH</i> Status in Low- and High-Grade Gliomas from MR Imaging
|Clinical Cancer Research|2017|392